Statements (27)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:drug
|
gptkbp:approvedBy |
gptkb:FDA
1996 |
gptkbp:ATCCode |
gptkb:M03BX02
|
gptkbp:contraindication |
severe liver impairment
|
gptkbp:drugClass |
muscle relaxant
|
gptkbp:form |
gptkb:tablet
capsule |
gptkbp:genericName |
gptkb:tizanidine
|
gptkbp:halfLife |
2.5 hours
|
https://www.w3.org/2000/01/rdf-schema#label |
Zanaflex
|
gptkbp:interactsWith |
gptkb:fluvoxamine
ciprofloxacin |
gptkbp:legalStatus |
Rx-only (US)
|
gptkbp:manufacturer |
gptkb:Acorda_Therapeutics
|
gptkbp:mechanismOfAction |
alpha-2 adrenergic agonist
|
gptkbp:metabolism |
liver
|
gptkbp:pregnancyCategory |
C (US)
|
gptkbp:prescriptionStatus |
prescription only
|
gptkbp:routeOfAdministration |
oral
|
gptkbp:sideEffect |
dizziness
drowsiness hypotension dry mouth |
gptkbp:usedFor |
muscle spasticity
|
gptkbp:bfsParent |
gptkb:tizanidine
|
gptkbp:bfsLayer |
8
|